Help us: Donate
Follow us on:
×

Menu

Back

Lifespan News – A New Senolytic Enters Human Trials

Lifespan News on Anti-Aging DrugsLifespan News on Anti-Aging Drugs

On Lifespan News this week, Brent Nally discusses skin regeneration, senolytics in human trials, T cell progenitors that boost the effectiveness of stem cell therapies, antibodies for glucosepane, and big pharma attempting to discover more senolytic drugs.

Further Reading

Regenerating Skin With a Single Protein

A New Senolytic Enters Human Trials

T Cell Progenitors Boost Stem Cell Therapy Effectiveness



Creating Anti-Glucosepane Antibodies

Big pharma enters senolytic drug discovery program

HELP SPREAD THE WORD
Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension:
Lifespan.io YouTube
Lifespan.io Facebook
Lifespan.io Twitter
Lifespan.io Instagram
Lifespan.io Instagram
Lifespan.io Discord
Thank You!

CategoryLifespan News, News
No Comments
Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.